AstraZeneca, GSK, Medica: Are healthcare stocks doing well now?

Be the First to Comment Read

AstraZeneca, GSK, Medica: Are healthcare stocks doing well now?

 AstraZeneca, GSK, Medica: Are healthcare stocks doing well now?
Image source: Guschenkova, Shutterstock

Highlights

  • Healthcare stocks have gained a lot of investor attention during the pandemic phase.
  • UK healthcare companies, such as AstraZeneca and GlaxoSmithKline, are adapting to the changing environment very quickly and many of them have bright prospects.

The already volatile stock market has been shaken further this year due to the recent developments in Ukraine and the investor sentiment remains sour so far. The Russia-Ukraine war escalated amid the existing issues like rising inflation and interest rates, soaring energy bills, and supply chain bottlenecks, that have emerged due to the pandemic. Overall, the market has been disrupted brutally in recent times.

UK healthcare and pharma stocks to buy now

2022 Kalkine Media®

However, even during these rough times when the market sentiment is down, investors are exploring investment options offering decent returns. During the pandemic phase, the healthcare sector has gained the attention of investors as stocks in this sector have provided investors with an opportunity to generate substantial returns in the long run.

The UK healthcare companies, like AstraZeneca, Dechra Pharmaceuticals, and GlaxoSmithKline, are adapting to the changing environment very quickly and many of them have bright prospects.

Here are 5 UK healthcare stocks that the investors may add to their portfolios after thorough research.

RELATED READ: National Grid, Drax, SSE: Should you buy these energy utility stocks now?

AstraZeneca plc (LON: AZN)

The current market cap of the Cambridge-headquartered pharma company, AstraZeneca plc, stands at £145,383.76 million as of 16 March 2022. AstraZeneca plc’s shares were trading at GBX 9,466.00, up by 0.89%, at 12:43 PM (GMT) on 16 March 2022. AstraZeneca is currently offering a dividend yield of 2.3% a year. The FTSE100 company has given a return of 35.77% to its shareholders over the last one year as of 16 March 2022, while its year-to-date return stands at 9.17%. 

 GlaxoSmithKline plc (LON: GSK)

The current market cap of the Brentford-headquartered pharma company, GlaxoSmithKline plc, stands at £79,816.43 million as of 16 March 2022. GlaxoSmithKline plc’s shares were trading at GBX 1,578.80, up by 0.56%, at 12:46 PM (GMT) on 16 March 2022. GlaxoSmithKline is currently offering a dividend yield of 5.1% a year. The FTSE100 company has given a return of 24.72% to its shareholders over the last one year as of 16 March 2022, however, its performance has gone down this year and its year-to-date return stands at -1.72%.

UK healthcare and pharma stocks to buy now

2022 Kalkine Media®

Dechra Pharmaceuticals plc (LON: DPH)

The current market cap of the veterinary pharma company, Dechra Pharmaceuticals plc, stands at £4,384.56 million as of 16 March 2022. Dechra Pharmaceuticals plc’s shares were trading at GBX 4,170.00, up by 3.07%, at 1:19 PM (GMT) on 16 March 2022. Dechra Pharmaceuticals is currently offering a dividend yield of 1.0% a year. The FTSE100 company has given a return of 21.19% to its shareholders over the last one year as of 16 March 2022, however, its performance has gone down this year and its year-to-date return stands at -21.62%.

RELATED READ: Cineworld (LON: CINE) may be out of FTSE 250 index: What’s next?

Mediclinic International plc (LON: MDC)

The current market cap of the private hospital group, Mediclinic International plc, stands at £2,511.05 million as of 16 March 2022. Mediclinic International plc’s shares were trading at GBX 346.00, up by 1.59%, at 1:22 PM (GMT) on 16 March 2022. The FTSE250 company has given a return of 9.78% to its shareholders over the last one year as of 16 March 2022, while its year-to-date return stands at 7.93%.

Medica Group plc (LON: MGP)

The current market cap of the teleradiology company, Medica Group plc, stands at £177.52 million as of 16 March 2022. Medica Group plc’s shares were trading at GBX 145.50, up by 0.35%, at 1:26 PM (GMT) on 16 March 2022. Medica Group is currently offering a dividend yield of 1.8% a year. The company has given a return of 1.39% to its shareholders over the last one year as of 16 March 2022, however its performance has gone down this year and its year-to-date return stands at -10.46%.

Disclaimer

Speak your Mind

Featured Articles